Related Experiment Video
Updated: Apr 30, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis
E Vidal1, A Sharathkumar, J Glover
1Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA.
Insights
Catheter-related thrombosis is common in children, affecting 20% of those with central venous catheters. Current thromboprophylaxis strategies show no significant benefit, highlighting the need for a well-powered trial to confirm efficacy.
Area of Science:
- Pediatric Thrombosis Research
- Vascular Access Complications
- Clinical Trial Methodology
Background:
- Catheter-related thrombosis (CRT) is a significant complication in pediatric patients with central venous catheters.
- Understanding the frequency of CRT is crucial for developing effective prevention strategies.
- Existing pediatric thromboprophylaxis trials have limitations that need to be addressed.
Purpose of the Study:
- To determine the frequency of catheter-related thrombosis in pediatric patients.
- To systematically review existing pediatric thromboprophylaxis trials to assess efficacy.
- To identify methodological pitfalls in previous pediatric thrombosis trials.
Main Methods:
- Systematic search of multiple databases (MEDLINE, EMBASE, Web of Science, Cochrane) up to December 2013.
- Inclusion of cohort studies and trials involving pediatric patients (0-18 years) with central venous catheters.
- Pooled frequency and risk ratios (RR) for thrombosis were estimated using random-effects models.
Main Results:
- Analysis of 37 articles involving 3128 patients revealed a pooled CRT frequency of 20% (95% CI: 0.16-0.24).
- Ten trials found no significant evidence that various thromboprophylaxis methods (heparin-bonded catheters, unfractionated heparin, LMWH, warfarin, antithrombin, nitroglycerin) reduced thrombosis risk.
- Most trials were underpowered or aimed to detect unrealistically large reductions in thrombosis, with missing outcome data being a limitation.
Conclusions:
- Catheter-related thrombosis is a prevalent issue in pediatric populations.
- There is a critical need for a large, multicenter trial with adequate power to detect clinically meaningful reductions in pediatric CRT.
- Future trials must prioritize minimizing missing outcome data to ensure reliable results.
Objectives:
In preparation for a pediatric randomized controlled trial on thromboprophylaxis, we determined the frequency of catheter-related thrombosis in children. We also systematically reviewed the pediatric trials on thromboprophylaxis to evaluate its efficacy and to identify possible pitfalls in the conduct of these trials.
Patients/Methods:
We searched MEDLINE, EMBASE, Web of Science and the Cochrane Central Register for Controlled Trials for articles published until December 2013. We included cohort studies and trials on patients aged 0-18 years with central venous catheters who underwent active surveillance for thrombosis with radiologic imaging. We estimated the pooled frequency of thrombosis and the pooled risk ratio (RR) with thromboprophylaxis by using a random effects model.
Results:
From 2651 articles identified, we analyzed 37 articles with 3128 patients. The pooled frequency of thrombosis was 0.20 (95% confidence interval [CI] 0.16-0.24). In 10 trials, we did not find evidence that heparin-bonded catheters (RR 0.34; 95%CI 0.01-7.68), unfractionated heparin (RR 0.93; 95% CI 0.57-1.51), low molecular weight heparin (RR 1.13; 95% CI 0.51-2.50), warfarin (RR 0.85; 95%CI 0.34-2.17), antithrombin concentrate (RR 0.76; 95% CI 0.38-1.55) or nitroglycerin (RR 1.53; 95%CI 0.57-4.10) reduced the risk of thrombosis. Most of the trials were either not powered for thrombosis or were powered to detect large, probably unachievable, reductions in thrombosis. Missing data on thrombosis also limited these trials.
Conclusions:
Catheter-related thrombosis is common in children. An adequately powered multicenter trial that can detect a modest, clinically significant reduction in thrombosis is critically needed. Missing outcome data should be minimized in this trial.
More Related Videos
05:51Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
09:57A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care